Search

LONDON -- The following information was released by the Association of the British Pharmaceutical Industry (ABPI): Posted in News by Press Office Following the first Labour budget for 14 years, [...]

Reuters - EU regulator backs Eisai-Biogen Alzheimer's drug after initial rejection - 15/11/2024 The European Union's drugs regulator on Thursday recommended approval of Eisai (4523.T), opens new tab and Biogen's [...]

Financial Times - AbbVie shares tumble after schizophrenia drug disappoints - 11/11/2024 Shares in AbbVie tumbled after the drugmaker revealed that an experimental treatment for schizophrenia, the main drug purchased [...]

Financial Times - Jeff Smith, the activist picking a fight with Covid hero Pfizer - 26/10/2024 Taking to the stage this week in front of an annual gathering of activist [...]

PMLiVE - Roche's Alecensa receives NICE recommendation to treat ALK-positive lung cancer - 21/10/2024 Roche's Alecensa (alectinib) has been recommended by the National Institute of Health and Care Excellence (NICE) [...]

China Daily - Global Edition - AstraZeneca expanding R&D pipeline in China - 14/10/2024 In an interview with China Daily, Sharon Barr, executive vice-president of biopharmaceuticals R&D at AstraZeneca, said [...]

Reuters - AstraZeneca in $1.9 bln licensing deal with HK-listed CSPC - 7/10/2024 AstraZeneca (AZN.L), opens new tab said on Monday it would pay up to $1.92 billion to CSPC [...]

China Daily - AstraZeneca announces plans for new innovations for China - 30/9/2024 United Kingdom-based biopharmaceutical giant AstraZeneca will add 10 to 15 new projects to the company's research and [...]

Financial Times - AstraZeneca drug fails to extend lives of breast cancer patients - 23/9/2024 Latest setback for Dato-DXd comes after disappointing results in lung cancer treatment earlier this month. [...]

Reuters - Sanofi, AstraZeneca win US approval for RSV therapy manufacturing line - 16/9/2024 Sanofi (SASY.PA), opens new tab and partner AstraZeneca (AZN.L), opens new tab have received approval from [...]

BioSpace - J&J Challenges AstraZeneca's Tagrisso With Phase III Data for Rybrevant, Lazcluze Combo - 9/9/2024 Johnson & Johnson on Sunday posted long-term follow-up data from the Phase III MARIPOSA [...]

Clinical Trials Arena - Bristol Myers Squibb's CAMZYOS offers benefits in oHCM trial - 2/9/2024 Bristol Myers Squibb (BMS) has unveiled new long-term follow-up results from the EXPLORER-LTE cohort of [...]

Financial Times - AstraZeneca threatens to move UK vaccine manufacturing to US - 23/8/2024 AstraZeneca has warned it could relocate its vaccine manufacturing site on Merseyside to Philadelphia amid a [...]

The Pharmaletter - UK must get ready for new cell and gene therapies, says ABPI - 19/8/2024 The UK's National Health Service (NHS) got off to a good start with [...]

Reuters - German panel endorses GSK, Pfizer RSV vaccines for elderly - 8/8/2024 Germany's influential vaccine advisory panel said on Thursday that everyone in the country who is 75-years old [...]

Bloomberg - Lilly CEO Says Weight-Loss Drug Will Be Off Shortage Soon - 2/8/2024 Eli Lilly & Co. expects its blockbuster weight-loss drug to officially come out of shortage in [...]

Reuters - Alzheimer's drug from Eisai and Biogen rejected in Europe - 27/7/2024 The European Union's drugs regulator has rejected Eisai and Biogen's, Leqembi treatment for early Alzheimer's disease, saying [...]

Pharmaceutical Times - Trial investigates faecal microbiota transplantation to treat rare liver disease - 22/7/2024 A new clinical trial led by the University of Birmingham aims to determine whether faecal [...]

Pharmaceutical Technology - NHS rolls out 'more convenient' Ocrevus injection for multiple sclerosis - 12/7/2024 England's National Health Service (NHS) has said that multiple sclerosis patients could have their hospital [...]

Pharmaceutical Technology - Pharmaceutical Times - AstraZeneca's Tagrisso plus chemotherapy wins EU approval for NSCLC - 5/7/2024 AstraZeneca has won approval from the European Commission for Tagrisso (osimertinib) in combination [...]

Reuters - AstraZeneca's COVID prevention drug application gets EU fast-track assessment - 1/7/2024 AstraZeneca opens new tab said that the European Union drug regulator has accepted a market authorisation application [...]

The Pharma Letter - GSK's Omjjara approved in Japan for treatment of myelofibrosis - 24/6/2024 Japan's Ministry of Health, Labor and Welfare (MHLW) has approved Omjjara (momelotinib) for the treatment [...]

Pharmaceutical Business Review - FDA accepts Eisai's sBLA for intravenous LEQEMBI to treat early Alzheimer's - 10/6/2024 The US Food and Drug Administration (FDA) has accepted the supplemental biologics license [...]

European Pharmaceutical Manufacturer - LabGenius Raises £35 Million - 29/5/2024 LabGenius has closed a £35 million Series B financing round. For complete story see: https://pharmaceuticalmanufacturer.media/pharma-manufacturing-news/pharma-finance-and-investment-news/labgenius-raises-%C2%A335-million/ Pharmaceutical Technology - Roche's PI3K [...]

Pharmaceutical Times - Researchers combine herpes virus with cancer vaccine to treat brain cancer in children - 23/5/2024 Researchers in the US and UK are exploring a new type of [...]

Reuters - GSK raises $1.5 bln from sale of remaining Haleon stake - 17/5/2024 GSK, opens new tab has raised 1.25 billion pounds ($1.52 billion) from a sale of its [...]

Reuters - Pfizer and AstraZeneca announce new investments of narly $1 billion in France - 12/5/2024 Pfizer opens new tab and AstraZeneca opens new tab announced on Sunday new investments [...]

London South East - AstraZeneca completes collaboration and investment deal with Cellectis - 6/5/2024 AstraZeneca PLC said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced [...]

London South East - AstraZeneca makes progress with Truqap and Enhertu cancer treatments - 29/4/2024 AstraZeneca PLC said its Truqap drug has been recommended for approval in the EU to [...]

Pharmaceutical Times - New NIHR HRC launched for cardiovascular and respiratory medicine - 22/4/2024 Guy's and St Thomas' and King's College London (KCL) have launched a new HealthTech Research Centre [...]

Reuters - US FDA allows expanded use of J&J, Bristol Myers cell therapies - 6/4/2024 The U.S. Food and Drug Administration has allowed cell therapies of Johnson & Johnson, opens [...]

Patient Care Online - Eisai Files sBLA for Lecanemab-irmb Maintenance Dosing, Reports Delay on SC Formulation - 1/4/2024 Eisai has submitted a supplemental biologics license application (sBLA) to the US [...]

Bloomberg - China Urges Lilly to Boost Investing Amid US Cutoff Threat - 22/3/2024 China's top trade official urged Eli Lilly & Co. to bolster its investment in the country, [...]

Bloomberg.com - Pfizer Plans to Sell About £2 Billion of Shares in Haleon - 18/3/2024 Pfizer Inc. plans to sell about £2 billion ($2.5 billion) of shares in Haleon Plc, [...]